A Bioequivalence Study of Dasatinib Tablet

Clinical trial NCT05640804 · COMPLETED

Trial details

NCT number: NCT05640804
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myelogenous, Chronic

Start date: 2018-09-09
Primary completion: 2018-10-03
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.